Article
Primary Plasma Cell Leukemia: Identity Card 2016.
Current treatment options in oncology - 1 Apr 2016
Musto Pellegrino, Simeon Vittorio, Todoerti Katia, Neri Antonino
Abstract excerpt
Primary plasma cell leukemia (PPCL) is an aggressive and rare variant of multiple myeloma (MM), characterized by peculiar adverse clinical and biological features. Though the poor outcome of PPCL has been slightly improved by novel treatments during the last 10 years, due to the limited number of available studies in this uncommon disease, optimal therapy remains a classic unmet clinical need. Anyway, in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
